Initiate Phase III in AAV by end of 2016
Report early aHUS results late 2016
Report Pancreatic Cancer early ORR results 3Q 2016 and initial PFS results 4Q 2016
CCX354: Rheumatoid Arthritis/Myeloma Bone Metastasis (CCR1)
Explore Partnering Options to Advance Program in IBD
CCR1 CCX354 Completed Phase IIa
Progress in TH17 Disease
* also known as CCX282 or Traficet-EN.